The global disposable syringes market size was valued at USD 13.8 Bn in 2022 and is likely to reach USD 23.5 Bn by 2031, expanding at a CAGR of 6.1% during 2023–2031. The market growth is driven by the rising prevalence of chronic diseases and increasing government initiatives for ensuring patient safety from hospital-acquired diseases.
The growing number of surgeries in worldwide healthcare facilities is resulting in the higher adoption of safe syringes across the healthcare sector. As per a recent survey by Eurostat, around 1.12 million cesarean sections were performed in the Europe region in the year 2020. Further, the increasing government initiatives to upgrade healthcare infrastructure and healthcare services for infection control and patient safety are expected to drive the market.
Disposable syringes are manufactured using plastic material. Their key applications are for administering drugs and vaccines to patients or for the extraction of blood samples. Plastic material is widely used for making disposable syringes owing to its lightweight and durable properties.
These syringes are substituted for glass hypodermic needles, to avoid spreading diseases from one person to another. The syringes are used entirely in healthcare services worldwide to deliver medicines to numerous patients following their innovation. Disposable syringes are often used to administer medication to individuals through the intravenous, intramuscular, or intradermal route.
The market report finds that the COVID-19 pandemic positively impacted the global disposable syringes market. The market has been catalyzed by increasing demand for disposable syringes due to the high spread of COVID-19 cases. This led to an increasing test of COVID-19 samples across worldwide healthcare and public & private places. In addition, the development of vaccines for rapid immunization increased the need for the adoption of disposable syringe practices to avoid contamination and the spread of the virus.
- As per the estimations of the United Nations Children's Agency in 2021, there is a potential shortage of up to 2.2 billion auto-disposable syringes that have built-in mechanisms to prevent re-use. This shortage has become a concern, especially as the delivery of COVID-19 vaccine doses to Africa is raging up after experiencing months of delay. Therefore, the demand for disposable syringes is expected to grow due to this impending shortfall.
Global Disposable Syringes Market Dynamics
Major Drivers
Increasing prevalence of chronic disorders is one of the key factors that drive the market. Chronic diseases such as diabetes can be managed by self-injecting medication. The age of chronic patients varies between 20-79 years.
- For instance, according to a news article published by the International Diabetes Federation 2021 report, the number of active patients with diabetes is around 537 million adults. The number of diabetic people is projected to reach 643 million in 2030. The IDF forecast shows that 1 in 8 adults is likely to be living with diabetes and estimates the number of individuals with diabetes number reaches 783 million by 2045.
Increasing activities by various NGOs to create safety awareness among individuals is another factor that propels the market. The growing need to control the spread of diseases such as HIV necessitates for the safe use of disposable syringes to avoid contamination.
- In April 2021, as per the Food and Drug Administration guidelines and recommendations to create awareness among patients and administration to the usage of disposable syringes, it was recommended that used needles need to be immediately placed in a disposable container. FDA cleared that the needle’s disposal container is majorly available in pharmacies, health care providers, medical supply companies, and online platforms.
Existing Restraints
Rising environmental concerns led to the formation of strict regulations and norms that are likely to hamper the market. Needles and syringes need to be discarded once they are used to reduce the risk of transmission of disease. The plastic that is used for the production of syringes is polypropylene. Of this material only 1% is recyclable and above that is non-biodegradable which leads to serious environmental issues.
Emerging Opportunities
Increasing cases of needlestick injuries create lucrative opportunities for the disposable syringes market. According to WHO, NSIs (Needle Stick Injuries) are responsible for the global incidence of HBV, HCV, and HIV/AIDS was 36.7%, 39%, and 4.4% respectively. As a result, various countries including the United States and countries in Europe have taken action by enacting regulations that mandate the use of disposable syringes.
- For Instance, In January 2022, according to statistics released by Greiner Bio-One International GmbH, needlestick injuries create significant concern for healthcare workers. The implementation of standards was introduced to safeguard healthcare professionals from potential exposure to bloodborne pathogens. They are also focused on innovating safety-engineered medical devices to enhance healthcare workers’ safety.
With major key players and governments across the globe implanting standards to use disposable syringes to reduce the risk of injuries, the market has new opportunities for further expansion in the coming years.
Scope of the Global Disposable Syringes Market Report
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Global Disposable Syringes Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Product Type (Safety Syringes, Pre-filled Syringes, and Conventional Syringes), Application (Therapeutic Injections and Immunization Injections), and End-user Hospitals, Clinics, Diagnostic Laboratories, Pharmaceutical Industry, Blood Banks, Home Care Settings, and Veterinary)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
B. Braun SE; BD; NIRPO; Novo Nordisk A/S; Terumo Corporation; Fresenius Kabi AG; Retractable Technologies, Inc.; Medtronic; FLEX LTD; UltiMed, Inc.; Baxter; and Vita Needle Company.
|
Global Disposable Syringes Market Segment Insights
Product Type Segment Analysis
Based on product type, the disposable syringes market is divided into safety syringes, pre-filled syringes, and conventional syringes. The safety syringes segment is expected to expand at a major growth rate during the projection period due to their effective result and protective benefits. Safety syringes have built-in safety mechanisms to eliminate the risk of needlestick injuries for healthcare workers and others. They also reduce the risk of patient-to-patient transmission of infections since they are disposed of after single use.
The conventional syringes segment is projected to hold a substantial market revenue share during the forecast period, owing to its capabilities of reducing the transmission of diseases in patients. Conventional syringes are made of plastic with visible graduation and are intended for one-time use.
The advantages of disposable conventional syringes include the elimination of the risk of infection from blood-borne pathogens such as Ebola virus, HIV, and Hepatitis B & C. In emerging economies around the world, governments are taking initiatives to increase the use of conventional disposable syringes & needles with the goal to reduce the transmission of diseases in patients.
Application Segment Analysis
On the basis of application, the market is segregated into therapeutic injections and immunization injections. The therapeutic injection segment is projected to register a considerable CAGR during the forecast period due to increasing awareness of blood donation around the world.
Blood donation plays a crucial role in providing lifesaving treatments to patients in an emergency situation. Therapeutic injections involve the administration of blood components or derived products that are known as the key factor for this process. These injections are used in various medical conditions such as anemia, cancer, blood disorders, and immune deficiencies.
Globally, organizations and individuals are actively participating in blood donation campaigns and initiatives to encourage blood donation. As a result, it helps to improve the availability of blood and blood products for therapeutic injections.
The immunization injection segment is projected to register a considerable CAGR during the forecast period due to the increasing attention on vaccination globally against infectious diseases such as COVID-19. Immunization is a process by which an individual is protected against a disease through vaccination.
Immunization programs are prioritized worldwide to prevent the spread of infectious diseases and also help to safeguard public health. Healthcare organizations and international bodies are actively sponsoring vaccination campaigns. The various government initiatives for widening vaccination drives create a higher demand for disposable syringes which are specifically designed for immunization purposes.
End-user Segment Analysis
On the basis of end-user, the disposable syringes market is segmented into hospitals, clinics, diagnostic laboratories, pharmaceutical industry, blood banks, home care settings, and veterinary. The hospital segment is expected to register a robust growth rate during the forecast period due to its capacity of providing complete healthcare services and priorities to control infection.
Hospitals provide a wide range of healthcare services including diagnostics, treatment, surgeries, and vaccinations. As a result, they require a significant volume of disposable syringes for various medical procedures, including medication administration, blood sample collection, and immunization. The large-scale operations and surgery options available at global hospital facilities are creating a high demand for disposable syringes.
Hospitals provide both inpatient and outpatient care. Inpatient settings involve prolonged hospital stays, where patients often require multiple injections and blood draws. Outpatient settings, such as hospitals and emergency departments, handle a high number of patients on a daily basis, necessitating the use of disposable syringes for efficient and safe healthcare delivery.
The clinic segment is projected to hold a significant market share in the coming years, due to the focus on convenience and safety for outpatient care and offers safety and convenience. Clinics primarily focus on outpatient care and provide a wide range of medical services and treatments. Disposable syringes offer convenience and safety to the numerous patients who take healthcare solutions in clinic settings.
In clinics, disposable syringes eliminate the need for sterilization, help to reduce the risk of cross-contamination, and ensure proper infection control of patients. The use of disposable syringes minimizes the chances of needlestick injuries and helps to maintain a clean and safe environment for both healthcare providers and patients in clinics.
Regional Analysis
In terms of region, the global disposable syringes market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period due to the increasing prevalence of diabetics in the region.
- For instance, according to a report published by International Diabetes Federation (IDF) in 2021, 51 million adults are living with diabetes and 12 million adults with diabetes are undiagnosed.
With the increasing number of diabetes patients in the region, the demand for disposable syringes is growing which helps in driving the market. Furthermore, the prevalence of HIV is a major concerning factor in the region for governments and healthcare systems. Apart from sexual transmission the virus also can be transmitted by the use of contaminated syringes or sharing needles. Such a high prevalence of HIV is increasing the demand for disposable syringes to prevent contamination and spread of HIV, these factors drive the market in the region.
- Data published In June 2021 by the National Institute of Health reported around 1.2 million individuals in the United States aged 13 and older are living with HIV. Despite the lack of a vaccine or cure, there is the recent availability of HIV prevention tools including HIV diagnostics tests, preexposure prophylaxis, and comprehensive syringe service programs.
The market in Asia Pacific is projected to grow rapidly during the forecast period, owing to the presence of prominent manufacturers, increasing awareness, and government measures to reassure single-use medical supplies to prevent infection. In Asia Pacific, an increasing geriatric population requires various healthcare treatments on a regular basis which is expected to drive the demand for disposable syringes. Further, the rising expansion of healthcare facilities in emerging economies such as India, to make healthcare accessible to a large population is projected to drive the demand for various hospital products including disposable syringes.
- In March 2021, Hindustan Syringes & Medical Devices (HMD), a leading manufacturer of disposable syringes in the world confirmed the order from the government to supply 265 million auto-disposable syringes. By the end of March, the company had fulfilled its past orders of 177.5 million AD syringes of 0.5 ml.
Segments
The global disposable syringes market has been segmented on the basis of
Product Type
- Safety Syringes
- Pre-filled Syringes
- Conventional Syringes
Application
- Therapeutic Injections
- Immunization Injections
End-user
- Hospitals
- Clinics
- Diagnostic Laboratories
- Pharmaceutical Industry
- Blood Banks
- Home Care Settings, And Veterinary
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- B. Braun SE
- BD
- Vita Needle Company
- NIRPO
- Novo Nordisk A/S
- Terumo Corporation
- Fresenius Kabi AG
- Retractable Technologies, Inc.
- Medtronic
- FLEX LTD
- UltiMed, Inc.
- Baxter
Competitive Landscape
Key players competing in the global disposable syringes market are B. Braun SE; BD; NIRPO; Novo Nordisk A/S; Terumo Corporation; Fresenius Kabi AG; Retractable Technologies, Inc.; Medtronic; FLEX LTD; UltiMed, Inc.; Baxter; and Vita Needle Company.
These prominent companies adopted development strategies including mergers, acquisitions, partnerships, collaboration, innovation in technology, new product launches, and production expansion to expand their consumer base worldwide. These renowned manufacturers and suppliers of disposable syringes cater to the healthcare industry's needs globally. They offer a wide range of disposable syringes, including various sizes, types, and safety features to meet the diverse requirements of healthcare facilities, clinics, and other end-users. For instance,
- In May 2023, BD a leading global medical technology manufacturer announced Advances in Prefilled Flush Syringes with Integrated 'Scrub-the-Hub' Innovation. This development disinfection unit is designed to strengthen compliance with infection prevention guidelines and support shortening nursing workflow.
Request For Customization
Enquiry Before Buying
Speak With Analyst
